Background Vulvar melanosis can occasionally be clinically challenging by mimicking an early melanoma.
Introduction
Vulvar melanosis, also referred to as 'vulvar lentiginosis' and 'vulvar melanotic macules', is an extensive macular pigmentation affecting the vulval skin, with the histological changes in basal hypermelanosis and a slight increase in the number of melanocytes. 1 It can occasionally be clinically atypical (asymmetric, large size, variegated pigmentation from light to dark brown and irregular borders) and sufficiently so to simulate a malignant lentiginous melanoma (MLM). In such cases, the differential diagnosis between melanosis and melanoma is challenging. Dermoscopy can be helpful, but in many cases, a biopsy is required for histopathological examination. 2 To date, a few series of vulvar melanoses examined using reflectance confocal microscopy (RCM) have been reported in the literature, including only a limited number of melanomas, and have led to the definition of typical RCM patterns of vulvar melanosis on the one hand and of MLM on the other hand. [3] [4] [5] [6] However, in these studies, most of the included benign lesions were clinically typical (small size, homogeneous pigmentation, regular shape). These are characterized by a ringed or a draped pattern with polycyclic papillae, although a low density of bright dendritic (stellate or triangular) cells in the basal layer of the epithelium is not unusual and remains consistent with vulvar melanosis. 7 Large atypical vulvar melanoses have received little attention to date, and little information about their natural history and risk of melanoma transformation is available in the literature. Several studies aiming at defining features to differentiate benign mucosal pigmentation (melanotic macules, melanosis) from MLM have been published during the last few years. 3, 5, 8 Recently, Uribe et al. 8 highlighted the usefulness of RCM for the diagnosis of melanoma and melanotic macules of the lip, while Laimer et al. 9 pointed out a subset of 'irregular dendritic type' mucosal melanotic macule with RCM features overlapping with early lentiginous melanomas. The purpose of this retrospective study was to report our experience of RCM in the initial evaluation and follow-up in the peculiar subset of clinically atypical vulvar melanosis.
Methods
Consecutive cases of large clinically atypical vulvar pigmentations from three centres (Lyon, France; Saint Etienne, France; Barcelona, Spain) between June 2013 and October 2016 were retrospectively evaluated. Patients were included if they had been referred to one of the study centres for a large clinically atypical/ ambiguous macular pigmentation (extensive or heterogeneous pigmentation and irregular shape) to rule out a melanoma and had undergone RCM examination and at least one biopsy, ideally guided by RCM. Patients were excluded if no biopsy was performed or if the pigmentation was clinically obviously benign. All patients gave informed consent before inclusion. Age and duration of objective follow-up (since first biopsy or since first dermoscopic or RCM examination) were recorded for each patient.
When it was available, dermoscopic analysis had been recorded in a computerized digital dermoscopy imaging system (FotoFinder Dermoscope, FotoFinder systems, Bad Birnbach, Germany). The dermoscopic images were retrospectively and anonymously analysed by an expert in dermoscopy (S.R-S.). They were classified as benign, equivocal or malignant. Lesions were classified equivocal or malignant as soon as they exhibited at least an area for which benignity could not be affirmed (according to previously published features). 2 Each patient underwent an RCM examination, as previously described and using a VivaScope 3000 â (Caliber Inc., Rochester, NY, USA) which provided 0.5 9 0.5 mm or 1 9 1 mm horizontal sections of the thickness of the epithelium from its surface to the upper chorion. 3 We relied on RCM reports of physicians of each centre (S.D., E.C., J-L.P., J.M., B.L.) to classify lesions as 'confocally benign', 'confocally equivocal' or 'confocally malignant'. A lesion was classified 'equivocal' or 'malignant' when RCM identified areas with bright cell density in the epithelium greater than previously described in melanosis or cells that exhibited morphological atypia, at least focally. 3 The following RCM features were retrospectively described and evaluated by two investigators by consensus (S.D. and C.T.) on the images recorded by the examiner: features suggestive of melanosis (ringed/draped pattern), the number of dendritic cells at the dermo-epithelial junction (DEJ) in representative areas of 1 mm 2 or 0.25 mm 2 in the focus with the greatest density (according to the images recorded by the operator), the morphology of cell bodies (triangular, fusiform and roundish), the mean body area, body length, body width of the two or three largest dendritic cells at the DEJ from representative areas of greatest density (using Adobe Photoshop CS6 Extended, Adobe Systems Software, Dublin, Ireland), the maximum number of bright cells around one papillae in the focus with the greatest density, the presence of interpapillary cells and the presence of cells in the papillae (dendritic cells or melanophages). Punch biopsies were systematically performed, targeted on equivocal or suspect areas when present. The histopathological diagnosis was the conclusion made by the pathologist from each centre. Immunohistochemistry with MelanA (DB Biotech, Kosice, Slovakia) and CD1a (DakoCytomation, Carpinteria, CA, USA) was performed on unstained slides in the department of dermatopathology of the Centre Hospitalier Lyon Sud (Lyon, France) when it was not available in the initial centre. The greatest number of cells per 1 mm stretch of DEJ (magnification 910) was counted on vertical section MelanA immunostaining on the focus of higher density of melanocytes for each case by two investigators (S.D and C.T) by consensus.
To evaluate correlation between the density of bright dendritic/roundish cells under RCM and the number of melanocytes on MelanA immunostaining in a 1 mm stretch of DEJ, Pearson's correlation and Kendall's concordance test were performed; to compare dermoscopy and RCM, we used Fisher's test (using IBM SPSS Statistics for Windows, Version 19.0, Armonk, NY, USA).
According to the ethics committee of our centre, this study was not registered in a public trial registry because it does not prospectively assign human subjects to intervention or comparison groups to evaluate the cause-and-effect relationship between a medical intervention and a health outcome. As data were collected retrospectively and patients management was not modified, according to the French law (n°2004-806, 9 August 2004), this study did not need to be approved by a research ethics committee.
Results
During the study period, 18 women aged from 35 to 91 years (mean: 52 years) were included. In six cases, atypical vulvar pigmentations were associated with a pre-existent lichen sclerosus and atrophicus (LSA) (Fig. 1) . The objective follow-up duration of 14 patients for whom data were available was between 16 and 136 months (mean: 53.7 months; four were lost to follow-up). Nine patients had at least two RCM examinations with followup between 3 and 48 months (mean: 21 months; Table 1 ).
Dermoscopy was available in 13 cases (Fig. 2) . In five cases, dermoscopy was equivocal, whereas RCM diagnosis was benign pigmentation ( Table 1 , Fig. 3 ) (in three of these cases, RCM identified very localized equivocal foci among an otherwise typically benign RCM aspect; these foci were not considered representative and large enough to lead the RCM expert to classify these lesions as 'equivocal' (cases 2, 6 and 9)). In two other cases, RCM identified larger equivocal foci among an otherwise typically benign RCM aspect on most of the lesion's area, leading the RCM expert to classify the lesions as 'equivocal' (cases 4 and 10) (Fig. 4) . RCM diagnosed the only MLM of the series (Fig. 5) . No statistical correlation between dermoscopy and RCM classification was found (P > 0.05). Among cases of histopathologically determined vulvar melanosis, RCM concluded a benign vulvar melanosis in 10 of 17 cases (58.8%), whereas dermoscopy did so in three of 12 cases (25.0%; Table 1 ). Classification of each case according to dermoscopy and RCM is provided in Table 1 .
For vulvar melanosis, in the areas of greatest density, the number of bright cells per field of view in RCM was between 0 and 38 per mm 2 Interpapillary bright dendritic cells were focally found in 11 cases (≤4 cells in seven cases, occasionally up to 6-8 cells); melanophages were found in 14 of 18 cases, particularly numerous in three of six cases of vulvar LSA (Table 2) . In histopathology, variations of melanocyte density on vulvar melanosis were sometimes observed on the same biopsy sample (Fig. 6) or even between two different biopsies of the same lesion and over time (Fig. 7) . CD1A immunostaining was always distributed on the whole thickness of the epithelium while MelanA-stained cells were only in the basal layer, which is in favour of the melanocytic origin of RCM identified bright cells at the DEJ. The final histopathological diagnosis was vulvar melanosis in 17 cases (four cases for which a melanocytic hyperplasia was highlighted on the histopathological report) and early mucosal MLM in one case (developed on atypical melanocytic hyperplasia; Table 1 ).
Discussion
In large clinically atypical vulvar pigmentation, using criteria described in a previous study, 3 RCM correctly classified approximately nearly a two-thirds of cases as benign with histopathological confirmation. This detection rate was better than that found for dermoscopy, and RCM identified the only MLM in this series. However, the number of melanoma cases included herein precluded any meaningful statistical analysis as to the sensitivity of RCM in this infrequent clinical situation; we therefore recommend an initial histopathological documentation in such cases, guided by RCM, even though an exclusively drapped or typical polycyclic pattern is highly indicative of typical melanosis. This result is consistent with Laimer et al.'s findings, who very recently published the results of a retrospective study on 42 pigmented macules of genitalia and lips. In their series, more melanotic macules were correctly classified as benign with RCM, Figure 2 Dermoscopic aspect of 12 vulvar melanosis (cases 1, 2, 4, 5, 6, 9, 10, 11, 15, 16, 17) and one MLM (case 7). Diagnostic methods for large vulvar pigmentation than when relying only on the clinical and dermoscopic images. They identified a subset of melanotic macules with RCM features overlapping with early MLM. Some of the RCM features which characterize this subset of lesions (higher density of dendritic cells around papillae and atypical bright cells in basal or suprabasal layers) were focally identified in some of the vulvar pigmentations of our series. Follow-up studies are rare, 10-14 and we report herein the longest median duration of objective follow-up for atypical genital melanosis. During this period, no melanoma transformation occurred during the follow-up, which suggests that the risk of genital melanoma occurrence among these patients, though difficult to precisely quantify, is probably small. This is in accordance with Haugh et al. 14 who recently reported a series of 41 pathologically confirmed genital (male and female) melanoses (22 of which were clinically atypical; 11 of which were greater than 1.5 cm); 30 cases were followed between 3 and 115 months (mean 30.5 months) with no melanoma occurrence even if the authors found nuclear atypias of melanocytes in a few of the clinically atypical melanoses, occasional suprabasal melanocytes in six cases and a variable density of melanocytes; therefore, to observe a slight or moderate melanocytic hyperplasia on a small biopsy sample of a large atypical pigmentation neither necessarily indicates nor precludes the hypothesis of a melanoma (while RCM allows evaluation of the whole surface of the pigmentation). This notion is substantiated by the present study: a variable density of melanocytes in histopathology was found in four cases, while atypical melanocytic hyperplasia was also observed in the only case of melanoma and, as noted by Uribe et al. 8 , 'distinguishing benign melanosis associated with an atypical melanocytic hyperplasia from an early and/or evolving melanoma in situ can be difficult and is at least partially subjective and pathologist-dependant'. The literature regarding the histopathological features of vulvar melanosis is poor and several decades old 10 (in particular, immunohistochemistry was not systematically performed); although the terms simple melanocytic hyperplasia and atypical melanocytic hyperplasia are routinely used, no threshold for melanocyte density has been defined to differentiate simple melanocytic hyperplasia, atypical melanocytic hyperplasia and early MLM. According to Saida et al. 15 , most pigmented macules on the mucous membrane showing variegated shades of brown and termed 'atypical melanosis' could be an early phase of melanoma in situ. As herein for the only case of melanoma, several case reports or case series reported the association of melanocytic hyperplasia and MLM, which could indeed suggest a continuum between melanocytic hyperplasia and early melanoma on mucous membranes. [16] [17] [18] Interestingly, in the study reported by Lotem et al. 17 , 66% of the patients had more than one focus of melanoma (separated by intact epithelium or arising during follow-up), in agreement with previously reported cases of mucosal melanoma. 13, [16] [17] [18] [19] [20] [21] [22] [23] [24] Therefore, a longterm risk of multifocal malignant transformation cannot be excluded; RCM is an interesting tool to provide a non-invasive microscopic monitoring of all pigmentation areas (as was the case in nine of the included patients), in particular in cases of melanosis with foci of melanotic hyperplasia, sometimes atypical. It is also interesting to note the results reported by Uribe et al. 14.14 lm), but the mean body length is close to that found in lip melanoma (21.08 lm). This could be related to the anatomical location (lip vs. vulva) or possibly reflects real morphological atypia of these focally observed bright cells with an eventual long-term malignant potential of such foci; only longer term follow-up will provide information about the future malignant potential of such foci. Moreover, we cannot totally exclude interoperator variability of such measures. Unfortunately, it was not possible to identify a correlation between density of melanocytes on MelanA immunostaining in a 1 mm stretch of DEJ and bright cells density in the foci of greatest density under RCM. This may be explained by the difficulty to perform a biopsy on the very same area that is examined with the RCM in this location, or by the fact that RCM evaluation is performed on horizontal sections whereas immunohistochemistry is performed on vertical sections. Interestingly, in our series, six melanoses were associated with LSA; all cases were correctly identified as benign with RCM; LSA has occasionally been reported to be associated with genital melanosis and postinflammatory vulvar pigmentations on the one hand and melanocytic proliferations on the other hand (naevi and melanoma), [25] [26] [27] but the number of cases reported herein was too low to draw any conclusion regarding this specific subset. Nevertheless, pigmentation arising on LSA is not always a postinflammatory pigmentation and the hypothesis of a melanocytic proliferation must be considered as well. 28 The main limitation of the present study is its retrospective nature. Due to the retrospective nature of the study, RCM classification was operator-dependant; as we cannot consider that the recorded/selected features were the most representative of each lesion (over-representation of the equivocal/atypical foci in the recorded images), we did not re-interpreted images but we relied on the operator reports for the RCM classification. There was only one melanoma in our series; this is also a limitation and that is why initial biopsy remains a rule in such atypical cases. Moreover, it must be kept in mind that a partial biopsy is always a limitation for an irrefutable diagnosis. That is why RCM follow-up must be associated with repeated biopsies in the most typical cases, as we did for patient 17. This case indeed typically illustrates the difficulty of such situations. Clinical appearance as well as dermoscopy is worrisome; RCM classified this case as equivocal. Repeated biopsies were in favour of a vulvar melanosis. In case of a smaller lesion, excision would be required as we cannot completely exclude the possibility of a slow-growing lentiginous melanoma. In this peculiar case, and considering the size of the pigmentation, a long-term combined RDM/histological follow-up is mandatory.
Conclusion
Large clinically atypical vulvar melanosis is clinically, dermoscopically and pathologically challenging. The results of the present study indicate that RCM is a helpful tool for initial evaluation of the whole surface of the pigmentation, to target initial biopsy sampling and to perform non-invasive monitoring in this peculiar clinical setting.
